Li Lin

Address:

1056 63 St #2FL, Brooklyn, NY 11219

Phone:

9176730889

VIN:

2T2BK1BA2BC116917

Make:

LEXUS

Model:

RX 350

Year:

2011

US Patent:

7126428, Oct 24, 2006

Filed:

Apr 5, 2005

Appl. No.:

11/100143

Inventors:

Li Lin - Saratoga CA, US
Arya Reza Behzad - Poway CA, US

Assignee:

Broadcom Corporation - Irvine CA

International Classification:

H03F 3/04

US Classification:

330311, 330261, 330278

Abstract:

A multi-stage, variable gain amplifier whose linearity is relatively insensitive to variations in gain control is disclosed. The amplifier includes a primary cascoded pair of transistors for producing a primary output current from an input voltage as a function of a primary cascode control voltage. The amplifier further includes one or more secondary cascoded pairs of transistors coupled to the primary cascoded pair of transistors for producing one or more secondary output currents from the input voltage as a function of one or more secondary cascode control voltages. The output current of the RF circuit is a sum of the primary output current and the one or more secondary output currents.

US Patent:

7355081, Apr 8, 2008

Filed:

Oct 15, 2004

Appl. No.:

10/966723

Inventors:

Kuo-Hsiung Lee - Chapel Hill NC, US
Li Lin - Chapel Hill NC, US
Charles C-Y Shih - Solana Beach CA, US
Ching-Yuan Su - San Diego CA, US
Junko Ishida - Tokyo, JP
Hironori Ohtsu - Matsubara, JP
Hideji Itokawa - Chapel Hill NC, US
Chawnshang Chang - Pittsford NY, US

Assignee:

The University of North Carolina at Chapel Hill - Chapel Hill NC
The University of Rochester Medical Center - Rochester NY
Androscience Corporation - San Diego CA

International Classification:

C07C 49/15

US Classification:

568 36, 568325, 580 53, 514544

Abstract:

The present invention relates to compounds capable of acting as androgen receptor antagonists, pharmaceutical formulations containing the same, and methods of use thereof. Such uses include, but are not limited to, use as antitumor agents, particularly for the treatment of cancers such as colon, skin and prostate cancer and to induce androgen receptor antagonist activity in a subject afflicted with an androgen-related affliction. Examples of androgen-related afflictions include, but are not limited to, baldness, hirsutism, behavioral disorders, acne, and uninhibited spermatogenesis wherein inhibition of spermatogenesis is so desired.

US Patent:

7595346, Sep 29, 2009

Filed:

Feb 13, 2008

Appl. No.:

12/030691

Inventors:

Kuo-Hsiung Lee - Chapel Hill NC, US
Li Lin - Chapel Hill NC, US
Charles C-Y Shih - Solana Beach CA, US
Ching-Yuan Su - San Diego CA, US
Junko Ishida - Tokyo, JP
Hironori Ohtsu - Matsubara, JP
Hideji Itokawa - Chapel Hill NC, US
Chawnshang Chang - Pittsford NY, US

Assignee:

The University of North Carolina at Chapel Hill - Chapel Hill NC
The University of Rochester Medical Center - Rochester NY
Androscience Corporation - San Diego CA

International Classification:

A01N 35/00
C07C 49/00

US Classification:

514705, 568325, 514679

Abstract:

The present invention relates to compounds capable of acting as androgen receptor antagonists, pharmaceutical formulations containing the same, and methods of use thereof. Such uses include, but are not limited to, use as antitumor agents, particularly for the treatment of cancers such as colon, skin and prostate cancer and to induce androgen receptor antagonist activity in a subject afflicted with an androgen-related affliction. Examples of androgen-related afflictions include, but are not limited to, baldness, hirsutism, behavioral disorders, acne, and uninhibited spermatogenesis wherein inhibition of spermatogenesis is so desired.

US Patent:

7709535, May 4, 2010

Filed:

Feb 13, 2008

Appl. No.:

12/030691

Inventors:

Kuo-Hsiung Lee - Chapel Hill NC, US
Li Lin - Chapel Hill NC, US
Charles C-Y Shih - Solana Beach CA, US
Ching-Yuan Su - San Diego CA, US
Junko Ishida - Tokyo, JP
Hironori Ohtsu - Matsubara, JP
Hideji Itokawa - Chapel Hill NC, US
Chawnshang Chang - Pittsford NY, US

Assignee:

The University of North Carolina at Chapel Hill - Chapel Hill NC
The University of Rochester Medical Center - Rochester NY
Androscience Corporation - San Diego CA

International Classification:

A01N 35/00
C07C 49/00

US Classification:

514705, 568325, 514679

Abstract:

The present invention relates to compounds capable of acting as androgen receptor antagonists, pharmaceutical formulations containing the same, and methods of use thereof. Such uses include, but are not limited to, use as antitumor agents, particularly for the treatment of cancers such as colon, skin and prostate cancer and to induce androgen receptor antagonist activity in a subject afflicted with an androgen-related affliction. Examples of androgen-related afflictions include, but are not limited to, baldness, hirsutism, behavioral disorders, acne, and uninhibited spermatogenesis wherein inhibition of spermatogenesis is so desired.

US Patent:

8198323, Jun 12, 2012

Filed:

Apr 12, 2010

Appl. No.:

12/758462

Inventors:

Kuo-Hsiung Lee - Chapel Hill NC, US
Li Lin - Chapel Hill NC, US
Charles C-Y Shih - Solana Beach CA, US
Ching-Yuan Su - San Diego CA, US
Junko Ishida - Tokyo, JP
Hironori Ohtsu - Matsubara, JP
Hideji Itokawa - Chapel Hill NC, US
Chawnshang Chang - Pittsford NY, US

Assignee:

The University of North Carolina at Chapel Hill - Chapel Hill NC
The University of Rochester Medical Center - Rochester NY
Androscience Corporation - San Diego CA

International Classification:

A61K 31/235
C12N 5/00
C07C 49/10

US Classification:

514543, 514544, 514679, 435375, 568325, 560 53

Abstract:

The present invention relates to compounds capable of acting as androgen receptor antagonists, pharmaceutical formulations containing the same, and methods of use thereof. Such uses include, but are not limited to, use as antitumor agents, particularly for the treatment of cancers such as colon, skin and prostate cancer and to induce androgen receptor antagonist activity in a subject afflicted with an androgen-related affliction. Examples of androgen-related afflictions include, but are not limited to, baldness, hirsutism, behavioral disorders, acne, and uninhibited spermatogenesis wherein inhibition of spermatogenesis is so desired.

US Patent:

8564471, Oct 22, 2013

Filed:

Dec 21, 2011

Appl. No.:

13/333058

Inventors:

Xiang Gao - San Jose CA, US
Chih-Wei Yao - Milpitas CA, US
Chi-Hung Lin - Fremont CA, US
Li Lin - Saratoga CA, US

Assignee:

Marvell International Ltd. - Hamilton

International Classification:

H03M 1/50

US Classification:

341166, 341155

Abstract:

Disclosed is a time-to-digital (TDC) converter comprising an analog voltage source. An analog-to-digital converter quantizes two voltage samples in response to receiving a first input signal at a first time tand a second input signal at a second time t. The first and second digital signals are combined to produce a digital signal that represents the difference (t−t).

US Patent:

8570887, Oct 29, 2013

Filed:

Nov 11, 2010

Appl. No.:

12/944031

Inventors:

Thomas B. Cho - Fremont CA, US
Li Lin - Saratoga CA, US
Mao Yu - San Jose CA, US
Atul Salhotra - Sunnyvale CA, US

Assignee:

Marvell World Trade Ltd. - St. Michael

International Classification:

G01R 31/08

US Classification:

370252, 455208

Abstract:

Apparatus having corresponding methods and non-transitory computer-readable media comprise an amplifier configured to amplify signals according to a bias current, wherein the signals represent packets of data; a packet module configured to recover the packets of data from the signals amplified by the amplifier; and a control module configured to control the bias current according to one or more characteristics of the packets of data.

US Patent:

8571497, Oct 29, 2013

Filed:

Nov 16, 2011

Appl. No.:

13/297420

Inventors:

Li Lin - Saratoga CA, US
Arnab Kumar Mitra - Sunnyvale CA, US
Harish Ramamurthy - Sunnyvale CA, US
Sergey Timofeev - Santa Clara CA, US
Lance Nagamine - Fremont CA, US
Brian Bosso - Santa Clara CA, US

Assignee:

Marvell International Ltd. - Hamilton

International Classification:

H01Q 11/12
H04B 1/04

US Classification:

4551272, 455118, 455126

Abstract:

A radio frequency transmitting system includes a programmable amplifier, a power amplifier, a power detector, and a calibration module. The programmable amplifier is configured to amplify an input signal to generate an amplified signal. The power amplifier is configured to output a transmit signal in response to the amplified signal. The transmit signal has a transmit power. The power detector is configured to generate a power measurement in response to the transmit power. The calibration module is configured to implement a plurality of feedback loops to adjust a gain of the programmable amplifier in response to a difference between the power measurement and a desired transmit power. The calibration module is configured to select one of the plurality of feedback loops in response to the desired transmit power.